Tag: the_lancet_neurology
-
Blood and Gene Test Combo Forecasts Alzheimer's Symptoms Years Before Onset
Columbia researchers find that combining a p-tau217 blood test with a genetic test for a high-risk APOE variant can predict when people at high risk of Alzheimer's will develop their first symptoms.
HealthScience & TechnologySportEnvironmentMedical ScienceClimate ChangeEducationMediaUSA Alzheimer's diseaseColumbia Universityp-tau217APOE geneThe Lancet NeurologyPTSD9/11 respondersnewsletter